{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T07:20:22Z","timestamp":1787815222136,"version":"build-2784847793"},"reference-count":298,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10142-026-02016-6","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T06:06:38Z","timestamp":1787810798000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RNA modifications as determinants of cancer cell death: from epitranscriptomic mechanisms to therapeutic targeting"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2774-6331","authenticated-orcid":false,"given":"Anirban Goutam","family":"Mukherjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit Kumar","family":"Bharti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepthi Maria","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavani Manoj","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sristy","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abilash Valsala","family":"Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"issue":"7675","key":"2016_CR1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nature24049","volume":"550","author":"OO Abudayyeh","year":"2017","unstructured":"Abudayyeh OO et al (2017) RNA targeting with CRISPR\u2013Cas13. Nature 550(7675):280\u2013284","journal-title":"Nature"},{"issue":"4","key":"2016_CR2","doi-asserted-by":"publisher","first-page":"e31176","DOI":"10.1002\/jcp.31176","volume":"239","author":"A Ak\u00e7a\u00f6z-Alasar","year":"2024","unstructured":"Ak\u00e7a\u00f6z-Alasar A et al (2024) Epitranscriptomics m(6)A analyses reveal distinct m(6)A marks under tumor necrosis factor \u03b1 (TNF-\u03b1)-induced apoptotic conditions in HeLa cells. J Cell Physiol 239(4):e31176","journal-title":"J Cell Physiol"},{"issue":"10","key":"2016_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.tcb.2024.08.002","volume":"34","author":"B Akg\u00fcl","year":"2024","unstructured":"Akg\u00fcl B, Ak\u00e7a\u00f6z-Alasar A, Sa\u011flam B (2024) RNA m6A methylation at the juxtaposition of apoptosis and RNA therapeutics. Trends Cell Biol 34(10):801\u2013804","journal-title":"Trends Cell Biol"},{"issue":"6","key":"2016_CR4","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2015.08.011","volume":"162","author":"CR Alarc\u00f3n","year":"2015","unstructured":"Alarc\u00f3n CR, Goodarzi H, Lee H, Liu X, Tavazoie S, Tavazoie SF (2015) HNRNPA2B1 is a mediator of m6A-dependent nuclear RNA processing events. Cell 162(6):1299\u20131308","journal-title":"Cell"},{"key":"2016_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cells11233905","author":"AA Alasar","year":"2022","unstructured":"Alasar AA, T\u00fcncel \u00d6, Gelmez AB, Sa\u011flam B, Vatansever \u0130E, Akg\u00fcl B (2022) Genomewide m(6)A mapping uncovers dynamic changes in the m(6)A epitranscriptome of cisplatin-treated apoptotic HeLa cells. Cells 11(23):3905 . https:\/\/doi.org\/10.3390\/cells11233905","journal-title":"Cells"},{"key":"2016_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116151","author":"\u00c1F \u00c1lvarez-Prado","year":"2025","unstructured":"\u00c1lvarez-Prado \u00c1F, Hern\u00e1ndez-Barranco A, Rentsch L, Costa CF, Joyce JA (2025) Cancer cell and microenvironmental rewiring by ADAR1 loss impairs glioblastoma tumor growth and extends survival. Cell Rep 44(9):116151 . https:\/\/doi.org\/10.1016\/j.celrep.2025.116151","journal-title":"Cell Rep"},{"key":"2016_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aah3941","author":"EM Amin","year":"2017","unstructured":"Amin EM et al (2017) The RNA-editing enzyme ADAR promotes lung adenocarcinoma migration and invasion by stabilizing FAK. Sci Signal 10(497):eaah3941 . https:\/\/doi.org\/10.1126\/scisignal.aah3941","journal-title":"Sci Signal"},{"issue":"5","key":"2016_CR8","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/leu.2014.16","volume":"28","author":"H Bansal","year":"2014","unstructured":"Bansal H et al (2014) WTAP is a novel oncogenic protein in acute myeloid leukemia. Leukemia 28(5):1171\u20131174","journal-title":"Leukemia"},{"issue":"7683","key":"2016_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nature24678","volume":"552","author":"I Barbieri","year":"2017","unstructured":"Barbieri I et al (2017) Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translation control. Nature 552(7683):126\u2013131","journal-title":"Nature"},{"issue":"6","key":"2016_CR9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","volume":"20","author":"I Barbieri","year":"2020","unstructured":"Barbieri I, Kouzarides T (2020) Role of RNA modifications in cancer. Nat Rev Cancer 20(6):303\u2013322","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"2016_CR11","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/s41587-021-00915-6","volume":"39","author":"O Begik","year":"2021","unstructured":"Begik O et al (2021) Quantitative profiling of pseudouridylation dynamics in native RNAs with nanopore sequencing. Nat Biotechnol 39(10):1278\u20131291","journal-title":"Nat Biotechnol"},{"issue":"14","key":"2016_CR12","doi-asserted-by":"publisher","first-page":"6026","DOI":"10.1158\/0008-5472.CAN-09-4730","volume":"70","author":"C Bellodi","year":"2010","unstructured":"Bellodi C et al (2010) Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis. Cancer Res 70(14):6026\u20136035","journal-title":"Cancer Res"},{"issue":"5","key":"2016_CR13","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.celrep.2013.04.030","volume":"3","author":"C Bellodi","year":"2013","unstructured":"Bellodi C et al (2013) H\/ACA small RNA dysfunctions in disease reveal key roles for noncoding RNA modifications in hematopoietic stem cell differentiation. Cell Rep 3(5):1493\u20131502","journal-title":"Cell Rep"},{"key":"2016_CR14","doi-asserted-by":"publisher","first-page":"3153362","DOI":"10.1155\/2022\/3153362","volume":"2022","author":"L Cai","year":"2022","unstructured":"Cai L, Li D, Feng Z, Gu X, Xu Q, Li Q (2022) YTHDF2 regulates macrophage polarization through NF-\u03baB and MAPK signaling pathway inhibition or p53 degradation. Dis Markers 2022:3153362","journal-title":"Dis Markers"},{"issue":"1","key":"2016_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41419-023-06407-6","volume":"15","author":"F Cao","year":"2024","unstructured":"Cao F et al (2024) METTL14 contributes to acute lung injury by stabilizing NLRP3 expression in an IGF2BP2-dependent manner. Cell Death Dis 15(1):43","journal-title":"Cell Death Dis"},{"issue":"1","key":"2016_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tips.2023.11.002","volume":"45","author":"J Cerneckis","year":"2024","unstructured":"Cerneckis J, Ming GL, Song H, He C, Shi Y (2024) The rise of epitranscriptomics: recent developments and future directions. Trends Pharmacol Sci 45(1):24\u201338","journal-title":"Trends Pharmacol Sci"},{"issue":"43","key":"2016_CR17","doi-asserted-by":"publisher","first-page":"17963","DOI":"10.1021\/ja3064149","volume":"134","author":"B Chen","year":"2012","unstructured":"Chen B et al (2012) Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor. J Am Chem Soc 134(43):17963\u201317971","journal-title":"J Am Chem Soc"},{"issue":"12","key":"2016_CR22","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41419-023-06241-w","volume":"14","author":"B Chen","year":"2023","unstructured":"Chen B et al (2023b) m6A and m5C modification of GPX4 facilitates anticancer immunity via STING activation. Cell Death Dis 14(12):809","journal-title":"Cell Death Dis"},{"issue":"1","key":"2016_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12935-023-03129-9","volume":"23","author":"C Chen","year":"2023","unstructured":"Chen C et al (2023a) ALKBH5-mediated CHAC1 depletion promotes malignant progression and decreases cisplatin-induced oxidative stress in gastric cancer. Cancer Cell Int 23(1):293","journal-title":"Cancer Cell Int"},{"issue":"3","key":"2016_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/cac2.12273","volume":"42","author":"J Chen","year":"2022","unstructured":"Chen J et al (2022) Aberrant translation regulated by METTL1\/WDR4-mediated tRNA N7-methylguanosine modification drives head and neck squamous cell carcinoma progression. Cancer Commun 42(3):223\u2013244","journal-title":"Cancer Commun"},{"issue":"D1","key":"2016_CR19","doi-asserted-by":"publisher","first-page":"D1396","DOI":"10.1093\/nar\/gkaa790","volume":"49","author":"K Chen","year":"2021","unstructured":"Chen K et al (2021) RMDisease: a database of genetic variants that affect RNA modifications, with implications for epitranscriptome pathogenesis. Nucleic Acids Res 49(D1):D1396\u2013D1404","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2016_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s11658-025-00794-8","volume":"30","author":"L Chen","year":"2025","unstructured":"Chen L et al (2025) Epitranscriptomic modifications in programmed cell death: mechanistic insights and implications for liver diseases. Cell Mol Biol Lett 30(1):116","journal-title":"Cell Mol Biol Lett"},{"issue":"6","key":"2016_CR18","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/hep.29683","volume":"67","author":"M Chen","year":"2018","unstructured":"Chen M et al (2018) RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology 67(6):2254\u20132270","journal-title":"Hepatology"},{"key":"2016_CR23","doi-asserted-by":"publisher","first-page":"102975","DOI":"10.1016\/j.redox.2023.102975","volume":"69","author":"S-J Chen","year":"2024","unstructured":"Chen S-J et al (2024a) Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via m5C modification of SLC7A11 mRNA. Redox Biol 69:102975","journal-title":"Redox Biol"},{"issue":"7","key":"2016_CR26","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.ccell.2021.04.017","volume":"39","author":"Y Cheng","year":"2021","unstructured":"Cheng Y et al (2021) N6-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation. Cancer Cell 39(7):958-972. e8","journal-title":"Cancer Cell"},{"issue":"4","key":"2016_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.106793","volume":"300","author":"Y Chen","year":"2024","unstructured":"Chen Y et al (2024b) 5-Methylcytosine transferase NSUN2 drives NRF2-mediated ferroptosis resistance in non-small cell lung cancer. J Biol Chem 300(4):106793","journal-title":"J Biol Chem"},{"key":"2016_CR27","doi-asserted-by":"publisher","first-page":"982606","DOI":"10.3389\/fcell.2022.982606","volume":"10","author":"JCT Cheung","year":"2022","unstructured":"Cheung JCT, Deng G, Wong N, Dong Y, Ng SSM (2022) More than a duologue: In-depth insights into epitranscriptomics and ferroptosis. Front Cell Dev Bioly 10:982606","journal-title":"Front Cell Dev Bioly"},{"issue":"4","key":"2016_CR28","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cell.2017.12.038","volume":"172","author":"H Chung","year":"2018","unstructured":"Chung H et al (2018) Human ADAR1 prevents endogenous RNA from triggering translational shutdown. Cell 172(4):811-824.e14","journal-title":"Cell"},{"issue":"11","key":"2016_CR29","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1016\/j.celrep.2017.02.059","volume":"18","author":"Q Cui","year":"2017","unstructured":"Cui Q et al (2017) M6A RNA methylation regulates the self-renewal and tumorigenesis of glioblastoma stem cells. Cell Rep 18(11):2622\u20132634","journal-title":"Cell Rep"},{"issue":"16","key":"2016_CR30","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1016\/j.molcel.2021.07.003","volume":"81","author":"Z Dai","year":"2021","unstructured":"Dai Z et al (2021) N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression. Mol Cell 81(16):3339-3355.e8","journal-title":"Mol Cell"},{"issue":"4","key":"2016_CR31","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.7150\/ijbs.100518","volume":"21","author":"Z Dai","year":"2025","unstructured":"Dai Z et al (2025) METTL3-mediated m6A modification of SLC7A11 enhances nasopharyngeal carcinoma radioresistance by inhibiting ferroptosis. Int J Biol Sci 21(4):1837\u20131851","journal-title":"Int J Biol Sci"},{"issue":"3","key":"2016_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41419-024-06486-z","volume":"15","author":"L Deng","year":"2024","unstructured":"Deng L et al (2024) Depletion of the N 6-methyladenosine (m6A) reader protein IGF2BP3 induces ferroptosis in glioma by modulating the expression of GPX4. Cell Death Dis 15(3):181","journal-title":"Cell Death Dis"},{"issue":"5","key":"2016_CR32","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41422-018-0034-6","volume":"28","author":"X Deng","year":"2018","unstructured":"Deng X, Su R, Weng H, Huang H, Li Z, Chen J (2018) RNA N(6)-methyladenosine modification in cancers: current status and perspectives. Cell Res 28(5):507\u2013517","journal-title":"Cell Res"},{"key":"2016_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.12.001","author":"X Deng","year":"2025","unstructured":"Deng X, Wu D, Zhao Y, Qing Y, Wu H, Chen J (2025) Epitranscriptomic control of cancer hallmarks: functions, mechanisms, and therapeutics of RNA modifications. Cancer Cell. https:\/\/doi.org\/10.1016\/j.ccell.2025.12.001","journal-title":"Cancer Cell"},{"key":"2016_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ph16020185","author":"H Diao","year":"2023","unstructured":"Diao H et al (2023) The m(6)A reader YTHDF1 promotes lung carcinoma progression via regulating ferritin mediate ferroptosis in an m(6)A-dependent manner. Pharmaceuticals (Basel) 16(2):185 . https:\/\/doi.org\/10.3390\/ph16020185","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"2016_CR36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40164-025-00648-1","volume":"14","author":"Y-P Ding","year":"2025","unstructured":"Ding Y-P, Liu C-C, Yu K-D (2025) RNA modifications in the tumor microenvironment: insights into the cancer-immunity cycle and beyond. Exp Hematol Oncol 14(1):48","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"2016_CR37","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1038\/s41467-019-09853-z","volume":"10","author":"A Dirkse","year":"2019","unstructured":"Dirkse A et al (2019) Stem cell-associated heterogeneity in glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment. Nat Commun 10(1):1787","journal-title":"Nat Commun"},{"issue":"5","key":"2016_CR38","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060\u20131072","journal-title":"Cell"},{"issue":"7397","key":"2016_CR39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11112","volume":"485","author":"D Dominissini","year":"2012","unstructured":"Dominissini D et al (2012) Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 485(7397):201\u2013206","journal-title":"Nature"},{"key":"2016_CR40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/bs.mie.2015.03.001","volume":"560","author":"D Dominissini","year":"2015","unstructured":"Dominissini D, Moshitch-Moshkovitz S, Amariglio N, Rechavi G (2015) Transcriptome-Wide Mapping of N\u2076-Methyladenosine by m\u2076A-Seq. Methods Enzymol 560:131\u2013147","journal-title":"Methods Enzymol"},{"issue":"1","key":"2016_CR41","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12951-024-02582-6","volume":"22","author":"F-L Dong","year":"2024","unstructured":"Dong F-L, Xu Z-Z, Wang Y-Q, Li T, Wang X, Li J (2024) Exosome-derived circUPF2 enhances resistance to targeted therapy by redeploying ferroptosis sensitivity in hepatocellular carcinoma. J Nanobiotechnol 22(1):298","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"2016_CR43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40164-025-00737-1","volume":"15","author":"L Du","year":"2026","unstructured":"Du L, Zhang Y, Luo J, He C, Lang J, Cao X (2026) Epigenetic and post-translational regulatory networks of ferroptosis in the tumor immune microenvironment. Exp Hematol Oncol 15(1):11","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"2016_CR42","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41419-025-08019-8","volume":"16","author":"Z-B Du","year":"2025","unstructured":"Du Z-B et al (2025) Hepatic steatosis and pyroptosis are induced by the hepatitis B virus X protein via B56\u03b1-METTL3 interaction-mediated m6A modification of the NLRP3 mRNA. Cell Death Dis 16(1):698","journal-title":"Cell Death Dis"},{"issue":"15","key":"2016_CR44","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1016\/j.molcel.2021.06.014","volume":"81","author":"JM Einstein","year":"2021","unstructured":"Einstein JM et al (2021) Inhibition of YTHDF2 triggers proteotoxic cell death in MYC-driven breast cancer. Mol Cell 81(15):3048-3064. e9","journal-title":"Mol Cell"},{"issue":"8","key":"2016_CR45","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41576-018-0006-1","volume":"19","author":"E Eisenberg","year":"2018","unstructured":"Eisenberg E, Levanon EY (2018) A-to-I RNA editing\u2014immune protector and transcriptome diversifier. Nat Rev Genet 19(8):473\u2013490","journal-title":"Nat Rev Genet"},{"issue":"5","key":"2016_CR46","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/s41375-019-0656-9","volume":"34","author":"IA Elcheva","year":"2019","unstructured":"Elcheva IA et al (2019) RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1. Leukemia 34(5):1354","journal-title":"Leukemia"},{"issue":"21","key":"2016_CR47","doi-asserted-by":"publisher","first-page":"10197","DOI":"10.1111\/jcmm.16957","volume":"25","author":"Z Fan","year":"2021","unstructured":"Fan Z et al (2021) Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2-dependent silencing of SLC7A11. J Cell Mol Med 25(21):10197\u201310212","journal-title":"J Cell Mol Med"},{"key":"2016_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2022.101369","author":"O Finet","year":"2022","unstructured":"Finet O, Yague-Sanz C, Hermand D (2022) Epitranscriptomic mapping of RNA modifications at single-nucleotide resolution using rhodamine sequencing (Rho-seq). STAR Protoc 3(2):101369 . https:\/\/doi.org\/10.1016\/j.xpro.2022.101369","journal-title":"STAR Protoc"},{"issue":"1","key":"2016_CR49","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1146\/annurev-biochem-061909-093311","volume":"82","author":"A Flotho","year":"2013","unstructured":"Flotho A, Melchior F (2013) Sumoylation: a regulatory protein modification in health and disease. Annu Rev Biochem 82(1):357\u2013385","journal-title":"Annu Rev Biochem"},{"issue":"6409","key":"2016_CR50","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1126\/science.aau1646","volume":"361","author":"M Frye","year":"2018","unstructured":"Frye M, Harada BT, Behm M, He C (2018) RNA modifications modulate gene expression during development. Science 361(6409):1346\u20131349","journal-title":"Science"},{"key":"2016_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116808","author":"J Fu","year":"2026","unstructured":"Fu J et al (2026) METTL3-mediated m6A on nascent RNA coordinates translational and transcriptional programs to activate the NLRP3 inflammasome in macrophages. Cell Rep 45(1):116808 . https:\/\/doi.org\/10.1016\/j.celrep.2025.116808","journal-title":"Cell Rep"},{"issue":"5","key":"2016_CR51","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrg3724","volume":"15","author":"Y Fu","year":"2014","unstructured":"Fu Y, Dominissini D, Rechavi G, He C (2014) Gene expression regulation mediated through reversible m6A RNA methylation. Nat Rev Genet 15(5):293\u2013306","journal-title":"Nat Rev Genet"},{"issue":"9","key":"2016_CR53","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00439-017-1837-0","volume":"136","author":"A Gallo","year":"2017","unstructured":"Gallo A, Vukic D, Michal\u00edk D, O\u2019connell MA, Keegan LP (2017) ADAR RNA editing in human disease; more to it than meets the I. Hum Genet 136(9):1265\u20131278","journal-title":"Hum Genet"},{"key":"2016_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2025.104861","author":"WL Gan","year":"2025","unstructured":"Gan WL, Chen L (2025) A-to-I RNA editing in hematologic immunity and malignancy. Exp Hematol. https:\/\/doi.org\/10.1016\/j.exphem.2025.104861","journal-title":"Exp Hematol"},{"key":"2016_CR55","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-3-031-45654-1_5","volume":"190","author":"WL Gan","year":"2023","unstructured":"Gan WL, Ng L, Ng BY, Chen L (2023) Adenosine-to-Inosine RNA Editing. Epigenet Oncol 190:143","journal-title":"Epigenet Oncol"},{"key":"2016_CR56","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.drup.2017.09.001","volume":"32","author":"NS Ganem","year":"2017","unstructured":"Ganem NS, Ben-Asher N, Lamm AT (2017) In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic. Drug Resist Updat 32:16\u201322","journal-title":"Drug Resist Updat"},{"issue":"1","key":"2016_CR57","doi-asserted-by":"publisher","first-page":"5450","DOI":"10.1038\/s41467-018-07824-4","volume":"9","author":"HS Gannon","year":"2018","unstructured":"Gannon HS et al (2018) Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells. Nat Commun 9(1):5450","journal-title":"Nat Commun"},{"issue":"1","key":"2016_CR58","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","volume":"7","author":"W Gao","year":"2022","unstructured":"Gao W, Wang X, Zhou Y, Wang X, Yu Y (2022) Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther 7(1):196","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2016_CR59","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13578-024-01286-6","volume":"14","author":"Z Gao","year":"2024","unstructured":"Gao Z, Zha X, Li M, Xia X, Wang S (2024) Insights into the m(6)A demethylases FTO and ALKBH5: structural, biological function, and inhibitor development. Cell Biosci 14(1):108","journal-title":"Cell Biosci"},{"issue":"3","key":"2016_CR60","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nmeth.4577","volume":"15","author":"DR Garalde","year":"2018","unstructured":"Garalde DR et al (2018) Highly parallel direct RNA sequencing on an array of nanopores. Nat Methods 15(3):201\u2013206","journal-title":"Nat Methods"},{"issue":"3","key":"2016_CR61","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.cell.2019.06.013","volume":"178","author":"MA Garcia-Campos","year":"2019","unstructured":"Garcia-Campos MA et al (2019) Deciphering the \u201cm6A code\u201d via antibody-independent quantitative profiling. Cell 178(3):731-747.e16","journal-title":"Cell"},{"issue":"1","key":"2016_CR62","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12943-023-01809-8","volume":"22","author":"R Garc\u00eda-V\u00edlchez","year":"2023","unstructured":"Garc\u00eda-V\u00edlchez R et al (2023) METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer. Mol Cancer 22(1):119","journal-title":"Mol Cancer"},{"issue":"1","key":"2016_CR63","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41698-025-01141-y","volume":"9","author":"W Ge","year":"2025","unstructured":"Ge W et al (2025) M6A-ALKBH5-dependent RBMS3-AS3 down-regulation suppresses ferroptosis to promote lung adenocarcinoma progression through HNRNPDL\/ZEB1\/GPX4 axis. NPJ Precision Oncology 9(1):356","journal-title":"NPJ Precision Oncology"},{"issue":"5759","key":"2016_CR64","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1126\/science.1120976","volume":"311","author":"MG Goll","year":"2006","unstructured":"Goll MG et al (2006) Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2. Science 311(5759):395\u2013398","journal-title":"Science"},{"key":"2016_CR65","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-1-4939-6807-7_5","volume":"1562","author":"AV Grozhik","year":"2017","unstructured":"Grozhik AV, Linder B, Olarerin-George AO, Jaffrey SR (2017) Mapping m(6)A at Individual-Nucleotide Resolution Using Crosslinking and Immunoprecipitation (miCLIP). Methods Mol Biol 1562:55\u201378","journal-title":"Methods Mol Biol"},{"issue":"35","key":"2016_CR66","doi-asserted-by":"publisher","first-page":"eadv9401","DOI":"10.1126\/sciadv.adv9401","volume":"11","author":"A Gupta","year":"2025","unstructured":"Gupta A et al (2025) DKC1-mediated pseudouridylation of rRNA targets hnRNP A1 to sustain IRES-dependent translation and ATF4-driven metabolic adaptation. Sci Adv 11(35):eadv9401","journal-title":"Sci Adv"},{"issue":"5","key":"2016_CR67","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.cell.2018.03.008","volume":"173","author":"N Guzzi","year":"2018","unstructured":"Guzzi N et al (2018) Pseudouridylation of tRNA-derived fragments steers translational control in stem cells. Cell 173(5):1204-1216.e26","journal-title":"Cell"},{"issue":"11","key":"2016_CR69","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/s41419-022-05376-6","volume":"13","author":"B-Y Han","year":"2022","unstructured":"Han B-Y, Liu Z, Hu X, Ling H (2022) HNRNPU promotes the progression of triple-negative breast cancer via RNA transcription and alternative splicing mechanisms. Cell Death Dis 13(11):940","journal-title":"Cell Death Dis"},{"issue":"1","key":"2016_CR70","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12(1):31\u201346","journal-title":"Cancer Discov"},{"issue":"7743","key":"2016_CR68","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-0916-x","volume":"566","author":"D Han","year":"2019","unstructured":"Han D et al (2019) Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells. Nature 566(7743):270\u2013274","journal-title":"Nature"},{"issue":"5","key":"2016_CR71","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41388-023-02882-5","volume":"43","author":"M He","year":"2024","unstructured":"He M et al (2024) M7G modification of FTH1 and pri-miR-26a regulates ferroptosis and chemotherapy resistance in osteosarcoma. Oncogene 43(5):341\u2013353","journal-title":"Oncogene"},{"issue":"5","key":"2016_CR72","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrg.2016.169","volume":"18","author":"M Helm","year":"2017","unstructured":"Helm M, Motorin Y (2017) Detecting RNA modifications in the epitranscriptome: predict and validate. Nat Rev Genet 18(5):275\u2013291","journal-title":"Nat Rev Genet"},{"issue":"10","key":"2016_CR73","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s00109-016-1416-1","volume":"94","author":"JE Heraud-Farlow","year":"2016","unstructured":"Heraud-Farlow JE, Walkley CR (2016) The role of RNA editing by ADAR1 in prevention of innate immune sensing of self-RNA. J Mol Med 94(10):1095\u20131102","journal-title":"J Mol Med"},{"issue":"18","key":"2016_CR74","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA (2019) The tumor microenvironment innately modulates cancer progression. Can Res 79(18):4557\u20134566","journal-title":"Can Res"},{"issue":"3","key":"2016_CR78","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H et al (2018) Recognition of RNA N 6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol 20(3):285\u2013295","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2016_CR79","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev-cancerbio-030419-033357","volume":"4","author":"H Huang","year":"2020","unstructured":"Huang H, Weng H, Deng X, Chen J (2020) RNA modifications in cancer: functions, mechanisms, and therapeutic implications. Annu Rev Cancer Biol 4(1):221\u2013240","journal-title":"Annu Rev Cancer Biol"},{"issue":"1","key":"2016_CR77","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/nar\/gku1276","volume":"43","author":"Y Huang","year":"2015","unstructured":"Huang Y et al (2015) Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5. Nucleic Acids Res 43(1):373\u2013384","journal-title":"Nucleic Acids Res"},{"key":"2016_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2025.112256","author":"Z Huang","year":"2025","unstructured":"Huang Z et al (2025) NCAPG confers ferroptosis resistance of hepatocellular carcinoma through NSUN2-mediated m5C modification. Cell Signal 138:112256 . https:\/\/doi.org\/10.1016\/j.cellsig.2025.112256","journal-title":"Cell Signal"},{"issue":"2","key":"2016_CR76","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41417-023-00697-w","volume":"31","author":"J Hu","year":"2024","unstructured":"Hu J, Chen K, Hong F, Gao G, Dai X, Yin H (2024) METTL3 facilitates stemness properties and tumorigenicity of cancer stem cells in hepatocellular carcinoma through the SOCS3\/JAK2\/STAT3 signaling pathway. Cancer Gene Ther 31(2):228\u2013236","journal-title":"Cancer Gene Ther"},{"issue":"21","key":"2016_CR75","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1016\/j.molcel.2023.09.018","volume":"83","author":"SB Hu","year":"2023","unstructured":"Hu SB et al (2023) ADAR1p150 prevents MDA5 and PKR activation via distinct mechanisms to avert fatal autoinflammation. Mol Cell 83(21):3869-3884.e7","journal-title":"Mol Cell"},{"issue":"2","key":"2016_CR81","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1021\/acschembio.0c00841","volume":"16","author":"S Huff","year":"2021","unstructured":"Huff S, Tiwari SK, Gonzalez GM, Wang Y, Rana TM (2021) m6A-RNA demethylase FTO inhibitors impair self-renewal in glioblastoma stem cells. ACS Chem Biol 16(2):324\u2013333","journal-title":"ACS Chem Biol"},{"issue":"35","key":"2016_CR82","doi-asserted-by":"publisher","first-page":"eaaz4551","DOI":"10.1126\/sciadv.aaz4551","volume":"6","author":"VV Ignatova","year":"2020","unstructured":"Ignatova VV et al (2020) METTL6 is a tRNA m3C methyltransferase that regulates pluripotency and tumor cell growth. Sci Adv 6(35):eaaz4551","journal-title":"Sci Adv"},{"issue":"7737","key":"2016_CR83","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41586-018-0768-9","volume":"565","author":"JJ Ishizuka","year":"2019","unstructured":"Ishizuka JJ et al (2019) Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade. Nature 565(7737):43\u201348","journal-title":"Nature"},{"key":"2016_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2026.108304","author":"R Izadpanah","year":"2026","unstructured":"Izadpanah R, Izadpanah A, Alt EU (2026) Epitranscriptomic circuits wiring the tumor microenvironment: a pharmacodynamic framework for clinical translation. Pharmacol Res 230:108304 . https:\/\/doi.org\/10.1016\/j.phrs.2026.108304","journal-title":"Pharmacol Res"},{"issue":"6","key":"2016_CR85","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00401-019-02062-4","volume":"138","author":"M Janin","year":"2019","unstructured":"Janin M et al (2019) Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program. Acta Neuropathol 138(6):1053\u20131074","journal-title":"Acta Neuropathol"},{"issue":"12","key":"2016_CR86","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nchembio.687","volume":"7","author":"G Jia","year":"2011","unstructured":"Jia G et al (2011) N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol 7(12):885\u2013887","journal-title":"Nat Chem Biol"},{"issue":"1","key":"2016_CR87","doi-asserted-by":"publisher","first-page":"e70190","DOI":"10.1002\/ctm2.70190","volume":"15","author":"S Jia","year":"2025","unstructured":"Jia S et al (2025b) Deciphering the pseudouridine nucleobase modification in human diseases: from molecular mechanisms to clinical perspectives. Clin Transl Med 15(1):e70190","journal-title":"Clin Transl Med"},{"key":"2016_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.218071","author":"W Jia","year":"2025","unstructured":"Jia W et al (2025a) Loss of ADAR1 in lung cancer activates anti-tumour immunity and suppresses tumour cell growth via the RIG-I\/MDA5-MAVS pathway. Cancer Lett 635:218071 . https:\/\/doi.org\/10.1016\/j.canlet.2025.218071","journal-title":"Cancer Lett"},{"issue":"1","key":"2016_CR89","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X et al (2021) The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther 6(1):74","journal-title":"Signal Transduct Target Ther"},{"key":"2016_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13122951","author":"T Jiang","year":"2025","unstructured":"Jiang T, Jiang N, Chen X, Xiong Z (2025) The role of NSUN family genes in m5C methylation and diseases. Biomedicines 13(12):2951. https:\/\/doi.org\/10.3390\/biomedicines13122951","journal-title":"Biomedicines"},{"issue":"12","key":"2016_CR92","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1002\/cbin.12245","volume":"48","author":"Y Jin","year":"2024","unstructured":"Jin Y et al (2024) The m6A modification of ACSL4 mRNA sensitized esophageal squamous cell carcinoma to irradiation via accelerating ferroptosis. Cell Biol Int 48(12):1877\u20131890","journal-title":"Cell Biol Int"},{"key":"2016_CR93","doi-asserted-by":"publisher","first-page":"858462","DOI":"10.3389\/fonc.2022.858462","volume":"12","author":"N Jyotsana","year":"2022","unstructured":"Jyotsana N, Ta KT, DelGiorno KE (2022) The role of cystine\/glutamate antiporter SLC7A11\/xCT in the pathophysiology of cancer. Front Oncol 12:858462","journal-title":"Front Oncol"},{"issue":"10","key":"2016_CR94","doi-asserted-by":"publisher","first-page":"2004344","DOI":"10.1002\/advs.202004344","volume":"8","author":"G Kan","year":"2021","unstructured":"Kan G et al (2021) Dual inhibition of DKC1 and MEK1\/2 synergistically restrains the growth of colorectal cancer cells. Adv Sci 8(10):2004344","journal-title":"Adv Sci"},{"issue":"6","key":"2016_CR95","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41576-022-00559-5","volume":"24","author":"Y Kong","year":"2023","unstructured":"Kong Y, Mead EA, Fang G (2023) Navigating the pitfalls of mapping DNA and RNA modifications. Nat Rev Genet 24(6):363\u2013381","journal-title":"Nat Rev Genet"},{"key":"2016_CR96","doi-asserted-by":"publisher","first-page":"109912","DOI":"10.1016\/j.cellsig.2020.109912","volume":"80","author":"A Lambrianidou","year":"2021","unstructured":"Lambrianidou A, Sereti E, Soupsana K, Komini C, Dimas K, Trangas T (2021) MTORC2 deploys the mRNA binding protein IGF2BP1 to regulate c-MYC expression and promote cell survival. Cell Signal 80:109912","journal-title":"Cell Signal"},{"key":"2016_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01763","volume":"10","author":"MM Lamers","year":"2019","unstructured":"Lamers MM, van den Hoogen BG, Haagmans BL (2019) ADAR1: \u201ceditor-in-chief\u201d of cytoplasmic innate immunity. Front Immunol 10:1763","journal-title":"Front Immunol"},{"issue":"3","key":"2016_CR99","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1021\/acs.molpharmaceut.0c00961","volume":"18","author":"H Lan","year":"2021","unstructured":"Lan H et al (2021) Tumor-associated macrophages promote oxaliplatin resistance via METTL3-mediated m6A of TRAF5 and necroptosis in colorectal cancer. Mol Pharm 18(3):1026\u20131037","journal-title":"Mol Pharm"},{"issue":"13","key":"2016_CR98","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1158\/0008-5472.CAN-20-4107","volume":"81","author":"Q Lan","year":"2021","unstructured":"Lan Q et al (2021) The emerging roles of RNA m6A methylation and demethylation as critical regulators of tumorigenesis, drug sensitivity, and resistance. Can Res 81(13):3431\u20133440","journal-title":"Can Res"},{"issue":"1","key":"2016_CR100","doi-asserted-by":"publisher","first-page":"7198","DOI":"10.1038\/s41467-021-27393-3","volume":"12","author":"A Leger","year":"2021","unstructured":"Leger A et al (2021) RNA modifications detection by comparative Nanopore direct RNA sequencing. Nat Commun 12(1):7198","journal-title":"Nat Commun"},{"issue":"11","key":"2016_CR112","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.17219\/acem\/200588","volume":"34","author":"B Li","year":"2025","unstructured":"Li B, Li SY, Yan YC (2025) IGF2BP2-mediated m6A modifies SLC7A11 to regulate proliferation and ferroptosis in non-small cell lung cancer cells. Adv Clin Exp Med 34(11):1937\u20131946","journal-title":"Adv Clin Exp Med"},{"key":"2016_CR106","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.omtn.2021.02.001","volume":"24","author":"H Li","year":"2021","unstructured":"Li H, Wu H, Wang Q, Ning S, Xu S, Pang D (2021b) Dual effects of N(6)-methyladenosine on cancer progression and immunotherapy. Mol Ther Nucleic Acids 24:25\u201339","journal-title":"Mol Ther Nucleic Acids"},{"key":"2016_CR108","doi-asserted-by":"publisher","first-page":"1055808","DOI":"10.3389\/fcell.2022.1055808","volume":"10","author":"P Li","year":"2022","unstructured":"Li P, Wang Y, Sun Y, Jiang S, Li J (2022) N 6-methyladenosine RNA methylation: from regulatory mechanisms to potential clinical applications. Front Cell Dev Biol 10:1055808","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"2016_CR103","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1002\/jcb.25957","volume":"118","author":"Q Li","year":"2017","unstructured":"Li Q et al (2017) NSUN2-Mediated m5C Methylation and METTL3\/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation. J Cell Biochem 118(9):2587\u20132598","journal-title":"J Cell Biochem"},{"issue":"1","key":"2016_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00453-8","volume":"6","author":"Q Li","year":"2021","unstructured":"Li Q et al (2021a) HIF-1\u03b1-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation. Signal Transduct Target Ther 6(1):76","journal-title":"Signal Transduct Target Ther"},{"issue":"21","key":"2016_CR101","doi-asserted-by":"publisher","first-page":"11083","DOI":"10.1074\/jbc.M115.711895","volume":"291","author":"Q Li","year":"2016","unstructured":"Li Q, Huang Y, Liu X, Gan J, Chen H, Yang CG (2016) Rhein inhibits AlkB repair enzymes and sensitizes cells to methylated DNA damage. J Biol Chem 291(21):11083\u201311093","journal-title":"J Biol Chem"},{"key":"2016_CR110","doi-asserted-by":"publisher","first-page":"133704","DOI":"10.1016\/j.jhazmat.2024.133704","volume":"468","author":"S-R Li","year":"2024","unstructured":"Li S-R et al (2024) ALKBH5 SUMOylation-mediated FBXW7 m6A modification regulates alveolar cells senescence during 1-nitropyrene-induced pulmonary fibrosis. J Hazard Mater 468:133704","journal-title":"J Hazard Mater"},{"issue":"11","key":"2016_CR107","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1111\/cas.15072","volume":"112","author":"XD Li","year":"2021","unstructured":"Li XD, Wang MJ, Zheng JL, Wu YH, Wang X, Jiang XB (2021) Long noncoding RNA just proximal to X-inactive specific transcript facilitates aerobic glycolysis and temozolomide chemoresistance by promoting stability of PDK1 mRNA in an m6A-dependent manner in glioblastoma multiforme cells. Cancer Sci 112(11):4543\u20134552","journal-title":"Cancer Sci"},{"issue":"56","key":"2016_CR102","doi-asserted-by":"publisher","first-page":"96103","DOI":"10.18632\/oncotarget.21726","volume":"8","author":"X Li","year":"2017","unstructured":"Li X et al (2017) The M6A methyltransferase METTL3: acting as a tumor suppressor in renal cell carcinoma. Oncotarget 8(56):96103","journal-title":"Oncotarget"},{"issue":"3","key":"2016_CR109","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/cncr.35048","volume":"130","author":"Y Li","year":"2024","unstructured":"Li Y, Cao J, Wang J, Wu W, Jiang L, Sun X (2024) Association of the m6A reader IGF2BP3 with tumor progression and brain-specific metastasis in breast cancer. Cancer 130(3):356\u2013374","journal-title":"Cancer"},{"issue":"1","key":"2016_CR104","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","volume":"31","author":"Z Li","year":"2017","unstructured":"Li Z et al (2017) FTO plays an oncogenic role in acute myeloid leukemia as a N6-methyladenosine RNA demethylase. Cancer Cell 31(1):127\u2013141","journal-title":"Cancer Cell"},{"key":"2016_CR114","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1709742","volume":"16","author":"C Li","year":"2025","unstructured":"Li C, Jiang X, Yuan Y, Wang Q (2025) METTL14 in tumor immunity: epitranscriptomic regulation and therapeutic potential. Front Immunol 16:1709742","journal-title":"Front Immunol"},{"key":"2016_CR113","doi-asserted-by":"publisher","first-page":"1702436","DOI":"10.3389\/fimmu.2025.1702436","volume":"16","author":"C Li","year":"2025","unstructured":"Li C, Yuan Y, Jiang X, Wang Q (2025) Roles and mechanisms of NSUN2-mediated RNA m(5)C modification in cancer progression and immune modulation. Front Immunol 16:1702436","journal-title":"Front Immunol"},{"issue":"5","key":"2016_CR111","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/mc.23892","volume":"64","author":"N Li","year":"2025","unstructured":"Li N, Jing Y, Xu L, Wang M (2025) METTL1 enhances RRP9 mRNA stability through m7G modification to drive colorectal tumorigenesis. Mol Carcinog 64(5):858\u2013869","journal-title":"Mol Carcinog"},{"issue":"5","key":"2016_CR115","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v17.i5.104076","volume":"17","author":"JN Liao","year":"2025","unstructured":"Liao JN et al (2025) Switching from messenger RNAs to noncoding RNAs, METTL3 is a novel colorectal cancer diagnosis and treatment target. World J Gastrointest Oncol 17(5):104076","journal-title":"World J Gastrointest Oncol"},{"issue":"6252","key":"2016_CR116","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1126\/science.aac7049","volume":"349","author":"BJ Liddicoat","year":"2015","unstructured":"Liddicoat BJ et al (2015) RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. Science 349(6252):1115\u20131120","journal-title":"Science"},{"issue":"8","key":"2016_CR121","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nmeth.3453","volume":"12","author":"B Linder","year":"2015","unstructured":"Linder B, Grozhik AV, Olarerin-George AO, Meydan C, Mason CE, Jaffrey SR (2015) Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome. Nat Methods 12(8):767\u2013772","journal-title":"Nat Methods"},{"issue":"3","key":"2016_CR117","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","volume":"62","author":"S Lin","year":"2016","unstructured":"Lin S, Choe J, Du P, Triboulet R, Gregory RI (2016) The m6A methyltransferase METTL3 promotes translation in human cancer cells. Mol Cell 62(3):335\u2013345","journal-title":"Mol Cell"},{"issue":"2","key":"2016_CR118","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.molcel.2018.06.001","volume":"71","author":"S Lin","year":"2018","unstructured":"Lin S, Liu Q, Lelyveld VS, Choe J, Szostak JW, Gregory RI (2018) Mettl1\/Wdr4-mediated m7G tRNA methylome is required for normal mRNA translation and embryonic stem cell self-renewal and differentiation. Mol Cell 71(2):244-255.e5","journal-title":"Mol Cell"},{"issue":"1","key":"2016_CR120","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41467-022-35710-7","volume":"14","author":"W Lin","year":"2023","unstructured":"Lin W et al (2023) Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation. Nat Commun 14(1):265","journal-title":"Nat Commun"},{"issue":"2","key":"2016_CR119","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ymthe.2022.10.012","volume":"31","author":"Z Lin","year":"2023","unstructured":"Lin Z et al (2023) N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis. Mol Ther 31(2):517\u2013534","journal-title":"Mol Ther"},{"issue":"3","key":"2016_CR129","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41587-022-01487-9","volume":"41","author":"C Liu","year":"2023","unstructured":"Liu C et al (2023) Absolute quantification of single-base m6A methylation in the mammalian transcriptome using GLORI. Nat Biotechnol 41(3):355\u2013366","journal-title":"Nat Biotechnol"},{"key":"2016_CR130","doi-asserted-by":"publisher","first-page":"1538658","DOI":"10.3389\/fimmu.2025.1538658","volume":"16","author":"F Liu","year":"2025","unstructured":"Liu F et al (2025) M6A epitranscriptomic modification in hepatocellular carcinoma: implications for the tumor microenvironment and immunotherapy. Front Immunol 16:1538658","journal-title":"Front Immunol"},{"issue":"2","key":"2016_CR123","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.1432","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu J et al (2014) A METTL3\u2013METTL14 complex mediates mammalian nuclear RNA N 6-adenosine methylation. Nat Chem Biol 10(2):93\u201395","journal-title":"Nat Chem Biol"},{"issue":"5","key":"2016_CR127","doi-asserted-by":"publisher","first-page":"e778","DOI":"10.1002\/ctm2.778","volume":"12","author":"L Liu","year":"2022","unstructured":"Liu L et al (2022) The N6\u2010methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma. Clin Transl Med 12(5):e778","journal-title":"Clin Transl Med"},{"issue":"1","key":"2016_CR126","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12943-022-01508-w","volume":"21","author":"L Liu","year":"2022","unstructured":"Liu L et al (2022) Insights into N6-methyladenosine and programmed cell death in cancer. Mol Cancer 21(1):32","journal-title":"Mol Cancer"},{"issue":"7540","key":"2016_CR124","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nature14234","volume":"518","author":"N Liu","year":"2015","unstructured":"Liu N, Dai Q, Zheng G, He C, Parisien M, Pan T (2015) N 6-methyladenosine-dependent RNA structural switches regulate RNA\u2013protein interactions. Nature 518(7540):560\u2013564","journal-title":"Nature"},{"issue":"7","key":"2016_CR125","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1093\/nar\/gkaa048","volume":"48","author":"T Liu","year":"2020","unstructured":"Liu T et al (2020) The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation. Nucleic Acids Res 48(7):3816\u20133831","journal-title":"Nucleic Acids Res"},{"key":"2016_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2023.156388","volume":"173","author":"W Liu","year":"2024","unstructured":"Liu W, Zeng H (2024) IGF2BP2 attenuates intestinal epithelial cell ferroptosis in colitis by stabilizing m6A-modified GPX4 mRNA. Cytokine 173:156388","journal-title":"Cytokine"},{"issue":"25","key":"2016_CR128","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/s41388-023-02704-8","volume":"42","author":"X Liu","year":"2023","unstructured":"Liu X et al (2023) m6A methylation regulates hypoxia-induced pancreatic cancer glycolytic metabolism through ALKBH5-HDAC4-HIF1\u03b1 positive feedback loop. Oncogene 42(25):2047\u20132060","journal-title":"Oncogene"},{"issue":"1","key":"2016_CR131","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1261\/rna.072785.119","volume":"26","author":"DA Lorenz","year":"2020","unstructured":"Lorenz DA, Sathe S, Einstein JM, Yeo GW (2020) Direct RNA sequencing enables m6A detection in endogenous transcript isoforms at base-specific resolution. RNA 26(1):19\u201328","journal-title":"RNA"},{"issue":"1","key":"2016_CR132","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13046-021-02065-8","volume":"40","author":"R Loveless","year":"2021","unstructured":"Loveless R, Bloomquist R, Teng Y (2021) Pyroptosis at the forefront of anticancer immunity. J Exp Clin Cancer Res 40(1):264","journal-title":"J Exp Clin Cancer Res"},{"key":"2016_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189489","author":"S Lu","year":"2025","unstructured":"Lu S, Liu J, Chen S, Li B, Ye Z (2025) M6A methylation in tumor immune microenvironment: multidimensional mechanism and targeted therapy strategies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1880(6):189489 . https:\/\/doi.org\/10.1016\/j.bbcan.2025.189489","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"issue":"2","key":"2016_CR134","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/hep.28885","volume":"65","author":"Jz Ma","year":"2017","unstructured":"Ma Jz et al (2017) METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N6-methyladenosine-dependent primary MicroRNA processing. Hepatology 65(2):529\u2013543","journal-title":"Hepatology"},{"issue":"12","key":"2016_CR135","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1016\/j.ymthe.2021.08.005","volume":"29","author":"J Ma","year":"2021","unstructured":"Ma J et al (2021) METTL1\/WDR4-mediated m7G tRNA modifications and m7G codon usage promote mRNA translation and lung cancer progression. Mol Ther 29(12):3422\u20133435","journal-title":"Mol Ther"},{"issue":"4","key":"2016_CR136","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.celrep.2014.10.041","volume":"9","author":"NM Mannion","year":"2014","unstructured":"Mannion NM et al (2014) The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. Cell Rep 9(4):1482\u20131494","journal-title":"Cell Rep"},{"issue":"7637","key":"2016_CR137","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature21022","volume":"541","author":"J Mauer","year":"2017","unstructured":"Mauer J et al (2017) Reversible methylation of m6Am in the 5\u2032 cap controls mRNA stability. Nature 541(7637):371\u2013375","journal-title":"Nature"},{"issue":"5","key":"2016_CR138","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","volume":"24","author":"P Meier","year":"2024","unstructured":"Meier P, Legrand AJ, Adam D, Silke J (2024) Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity. Nat Rev Cancer 24(5):299\u2013315","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"2016_CR300","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41419-024-06963-5","volume":"15","author":"X. Meng","year":"2024","unstructured":"Meng, X., Wang, Z., Yang, Q., Liu, Y., Gao, Y., Chen, H., . . . Sun, G. (2024). Intracellular C5aR1 inhibits ferroptosis in glioblastoma through METTL3-dependent m6A methylation of GPX4. Cell Death and Disease, 15(10), 729 https:\/\/doi.org\/10.1038\/s41419-024-06963-5","journal-title":"Cell Death and Disease"},{"issue":"12","key":"2016_CR139","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/s41592-019-0570-0","volume":"16","author":"KD Meyer","year":"2019","unstructured":"Meyer KD (2019) DART-seq: an antibody-free method for global m6A detection. Nat Methods 16(12):1275\u20131280","journal-title":"Nat Methods"},{"key":"2016_CR140","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev-cellbio-100616-060758","volume":"33","author":"KD Meyer","year":"2017","unstructured":"Meyer KD, Jaffrey SR (2017) Rethinking m6A readers, writers, and erasers. Annu Rev Cell Dev Biol 33:319\u2013342","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"7","key":"2016_CR141","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","volume":"149","author":"KD Meyer","year":"2012","unstructured":"Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR (2012) Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2032 UTRs and near stop codons. Cell 149(7):1635\u20131646","journal-title":"Cell"},{"issue":"21\u201322","key":"2016_CR142","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1080\/17520363.2024.2416886","volume":"18","author":"A Mo","year":"2024","unstructured":"Mo A, Wang H (2024) WTAP-mediated m6A modification regulates NLRP3\/Caspase-1\/GSDMD to inhibit pyroptosis and exacerbate colorectal cancer. Biomark Med 18(21\u201322):945\u2013955","journal-title":"Biomark Med"},{"issue":"12","key":"2016_CR143","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/j.molcel.2022.05.029","volume":"82","author":"S Murakami","year":"2022","unstructured":"Murakami S, Jaffrey SR (2022) Hidden codes in mRNA: Control of gene expression by m(6)A. Mol Cell 82(12):2236\u20132251","journal-title":"Mol Cell"},{"issue":"3","key":"2016_CR144","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/intimm\/dxac056","volume":"35","author":"T Nakahama","year":"2023","unstructured":"Nakahama T, Kawahara Y (2023) The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways. Int Immunol 35(3):123\u2013133","journal-title":"Int Immunol"},{"issue":"2","key":"2016_CR145","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrm.2015.4","volume":"17","author":"K Nishikura","year":"2016","unstructured":"Nishikura K (2016) A-to-I editing of coding and non-coding RNAs by ADARs. Nat Rev Mol Cell Biol 17(2):83\u201396","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2016_CR146","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.freeradbiomed.2015.01.028","volume":"82","author":"Y Niu","year":"2015","unstructured":"Niu Y, DesMarais TL, Tong Z, Yao Y, Costa M (2015) Oxidative stress alters global histone modification and DNA methylation. Free Radic Biol Med 82:22\u201328","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"2016_CR147","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-019-1004-4","volume":"18","author":"Y Niu","year":"2019","unstructured":"Niu Y et al (2019) RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Mol Cancer 18(1):46","journal-title":"Mol Cancer"},{"issue":"1","key":"2016_CR148","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01263-w","volume":"20","author":"P Nombela","year":"2021","unstructured":"Nombela P, Miguel-L\u00f3pez B, Blanco S (2021) The role of m6A, m5C and \u03a8 RNA modifications in cancer: novel therapeutic opportunities. Mol Cancer 20(1):18","journal-title":"Mol Cancer"},{"key":"2016_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123505","volume":"368","author":"Y-J Ou","year":"2025","unstructured":"Ou Y-J et al (2025) The combination of BET and METTL3 inhibitors elicits synergistic antitumor effects in ovarian cancer cells via reducing SP1 and BCL-2 expression. Life Sci 368:123505","journal-title":"Life Sci"},{"issue":"1","key":"2016_CR150","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.stem.2019.03.021","volume":"25","author":"J Paris","year":"2019","unstructured":"Paris J et al (2019) Targeting the RNA m6A reader YTHDF2 selectively compromises cancer stem cells in acute myeloid leukemia. Cell Stem Cell 25(1):137-148. e6","journal-title":"Cell Stem Cell"},{"key":"2016_CR151","doi-asserted-by":"publisher","first-page":"e49658","DOI":"10.7554\/eLife.49658","volume":"9","author":"MT Parker","year":"2020","unstructured":"Parker MT et al (2020) Nanopore direct RNA sequencing maps the complexity of Arabidopsis mRNA processing and m6A modification. elife 9:e49658","journal-title":"elife"},{"issue":"30","key":"2016_CR152","doi-asserted-by":"publisher","first-page":"eadg1805","DOI":"10.1126\/sciadv.adg1805","volume":"9","author":"C Pederiva","year":"2023","unstructured":"Pederiva C et al (2023) Control of protein synthesis through mRNA pseudouridylation by dyskerin. Sci Adv 9(30):eadg1805","journal-title":"Sci Adv"},{"issue":"3","key":"2016_CR153","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1261\/rna.080858.125","volume":"32","author":"HNC Pike","year":"2026","unstructured":"Pike HNC, Schwartz S (2026) High-stoichiometry m(6)A sites are evolutionarily conserved. RNA 32(3):328\u2013340","journal-title":"RNA"},{"issue":"1","key":"2016_CR154","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13046-024-03032-9","volume":"43","author":"Y Qiao","year":"2024","unstructured":"Qiao Y et al (2024) Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11\/GPX4 expression. J Exp Clin Cancer Res 43(1):108","journal-title":"J Exp Clin Cancer Res"},{"issue":"32","key":"2016_CR155","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1038\/s41388-025-03457-2","volume":"44","author":"S Qu","year":"2025","unstructured":"Qu S et al (2025) PRMT5 K240lac confers ferroptosis resistance via ALKBH5\/SLC7A11 axis in colorectal cancer. Oncogene 44(32):2814\u20132830","journal-title":"Oncogene"},{"issue":"13","key":"2016_CR156","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1016\/j.molcel.2022.04.010","volume":"82","author":"N Raj","year":"2022","unstructured":"Raj N et al (2022) The Mettl3 epitranscriptomic writer amplifies p53 stress responses. Mol Cell 82(13):2370-2384.e10","journal-title":"Mol Cell"},{"issue":"1","key":"2016_CR157","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.tcb.2024.06.006","volume":"35","author":"J Rehwinkel","year":"2025","unstructured":"Rehwinkel J, Mehdipour P (2025a) ADAR1: from basic mechanisms to inhibitors. Trends Cell Biol 35(1):59\u201373","journal-title":"Trends Cell Biol"},{"issue":"sup1","key":"2016_CR158","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/15476286.2021.1969113","volume":"18","author":"P Rengaraj","year":"2021","unstructured":"Rengaraj P et al (2021) Interplays of different types of epitranscriptomic mRNA modifications. RNA Biol 18(sup1):19\u201330","journal-title":"RNA Biol"},{"key":"2016_CR159","doi-asserted-by":"publisher","first-page":"1716445","DOI":"10.3389\/fimmu.2026.1716445","volume":"17","author":"MA Riaz","year":"2026","unstructured":"Riaz MA et al (2026) Context-dependent functions of ALKBH5: a mechanistic framework linking cellular stress responses, immune regulation, viral infection, and therapeutic vulnerabilities. Front Immunol 17:1716445","journal-title":"Front Immunol"},{"key":"2016_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113704","author":"M Rivera","year":"2024","unstructured":"Rivera M et al (2024) Malignant A-to-I RNA editing by ADAR1 drives T cell acute lymphoblastic leukemia relapse via attenuating dsRNA sensing. Cell Rep 43(2):113704 . https:\/\/doi.org\/10.1016\/j.celrep.2024.113704","journal-title":"Cell Rep"},{"issue":"7","key":"2016_CR161","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","volume":"169","author":"IA Roundtree","year":"2017","unstructured":"Roundtree IA, Evans ME, Pan T, He C (2017) Dynamic RNA modifications in gene expression regulation. Cell 169(7):1187\u20131200","journal-title":"Cell"},{"key":"2016_CR163","doi-asserted-by":"publisher","DOI":"10.3390\/genes16080951","author":"DM Ruden","year":"2025","unstructured":"Ruden DM (2025) Uncovering the epitranscriptome: a review on mRNA modifications and emerging frontiers. Genes16(8):951. https:\/\/doi.org\/10.3390\/genes16080951","journal-title":"Genes"},{"key":"2016_CR164","doi-asserted-by":"publisher","DOI":"10.3390\/ph11040114","author":"N Santana-Codina","year":"2018","unstructured":"Santana-Codina N, Mancias JD (2018) The role of NCOA4-mediated ferritinophagy in health and disease. Pharmaceuticals (Basel) 11(4):114 . https:\/\/doi.org\/10.3390\/ph11040114","journal-title":"Pharmaceuticals (Basel)"},{"key":"2016_CR165","doi-asserted-by":"publisher","DOI":"10.3390\/genes12030345","author":"MR Schaefer","year":"2021","unstructured":"Schaefer MR (2021) The regulation of RNA modification systems: the next frontier in epitranscriptomics? Genes (Basel) 12(3):345 . https:\/\/doi.org\/10.3390\/genes12030345","journal-title":"Genes (Basel)"},{"key":"2016_CR166","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.170077","author":"M Schaefer","year":"2017","unstructured":"Schaefer M, Kapoor U, Jantsch MF (2017) Understanding RNA modifications: the promises and technological bottlenecks of the \u2018epitranscriptome.\u2019 Open Biol 7(5):170077 . https:\/\/doi.org\/10.1098\/rsob.170077","journal-title":"Open Biol"},{"issue":"10","key":"2016_CR167","doi-asserted-by":"publisher","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","volume":"24","author":"M Schieber","year":"2014","unstructured":"Schieber M, Chandel NS (2014) ROS function in redox signaling and oxidative stress. Curr Biol 24(10):R453\u2013R462","journal-title":"Curr Biol"},{"issue":"12","key":"2016_CR168","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.trecan.2016.10.016","volume":"2","author":"L Schito","year":"2016","unstructured":"Schito L, Semenza GL (2016) Hypoxia-inducible factors: master regulators of cancer progression. Trends Cancer 2(12):758\u2013770","journal-title":"Trends Cancer"},{"issue":"1","key":"2016_CR169","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12915-020-00769-5","volume":"18","author":"U Schumann","year":"2020","unstructured":"Schumann U et al (2020) Multiple links between 5-methylcytosine content of mRNA and translation. BMC Biol 18(1):40","journal-title":"BMC Biol"},{"issue":"1","key":"2016_CR170","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.cell.2014.08.028","volume":"159","author":"S Schwartz","year":"2014","unstructured":"Schwartz S et al (2014) Transcriptome-wide mapping reveals widespread dynamic-regulated pseudouridylation of ncRNA and mRNA. Cell 159(1):148\u2013162","journal-title":"Cell"},{"key":"2016_CR171","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","volume":"133","author":"TM Seibt","year":"2019","unstructured":"Seibt TM, Proneth B, Conrad M (2019) Role of GPX4 in ferroptosis and its pharmacological implication. Free Radic Biol Med 133:144\u2013152","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"2016_CR172","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/nar\/gkaa1193","volume":"49","author":"T Selmi","year":"2021","unstructured":"Selmi T et al (2021) Sequence-and structure-specific cytosine-5 mRNA methylation by NSUN6. Nucleic Acids Res 49(2):1006\u20131022","journal-title":"Nucleic Acids Res"},{"key":"2016_CR173","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-026-02706-6","author":"S Shang","year":"2026","unstructured":"Shang S et al (2026) RNA methylation in cell death: mechanisms and clinical applications. Mol Cancer 25(1):199 . https:\/\/doi.org\/10.1186\/s12943-026-02706-6","journal-title":"Mol Cancer"},{"issue":"11","key":"2016_CR174","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1158\/0008-5472.CAN-25-2893","volume":"86","author":"X She","year":"2026","unstructured":"She X et al (2026) METTL3 methylation induces decay of endogenous retroelement transcripts to promote tumor immune evasion. Cancer Res 86(11):2722\u20132742","journal-title":"Cancer Res"},{"issue":"3","key":"2016_CR175","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/cr.2017.15","volume":"27","author":"H Shi","year":"2017","unstructured":"Shi H et al (2017) YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA. Cell Res 27(3):315\u2013328","journal-title":"Cell Res"},{"issue":"4","key":"2016_CR176","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","volume":"74","author":"H Shi","year":"2019","unstructured":"Shi H, Wei J, He C (2019a) Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers. Mol Cell 74(4):640\u2013650","journal-title":"Mol Cell"},{"issue":"1","key":"2016_CR177","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1038\/s41467-019-12801-6","volume":"10","author":"Y Shi","year":"2019","unstructured":"Shi Y et al (2019b) YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression. Nat Commun 10(1):4892","journal-title":"Nat Commun"},{"issue":"1","key":"2016_CR178","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12943-024-02132-6","volume":"23","author":"JX Shi","year":"2024","unstructured":"Shi JX et al (2024) RNA m6A modification in ferroptosis: implications for advancing tumor immunotherapy. Mol Cancer 23(1):213","journal-title":"Mol Cancer"},{"key":"2016_CR179","doi-asserted-by":"publisher","first-page":"101181","DOI":"10.1016\/j.drup.2024.101181","volume":"78","author":"C-J Shi","year":"2025","unstructured":"Shi C-J et al (2025) 5-methylcytosine methylation of MALAT1 promotes resistance to sorafenib in hepatocellular carcinoma through ELAVL1\/SLC7A11-mediated ferroptosis. Drug Resist Updates 78:101181","journal-title":"Drug Resist Updates"},{"key":"2016_CR180","doi-asserted-by":"publisher","first-page":"1772310","DOI":"10.3389\/fmolb.2026.1772310","volume":"13","author":"Q Shi","year":"2026","unstructured":"Shi Q et al (2026) Recent advances in m6A RNA modification in hepatocellular carcinoma: from mechanisms to therapeutic potential. Front Mol Biosci 13:1772310","journal-title":"Front Mol Biosci"},{"issue":"3","key":"2016_CR181","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/narcan\/zcae037","volume":"6","author":"R Shoemaker","year":"2024","unstructured":"Shoemaker R, Huang MF, Wu YS, Huang CS, Lee DF (2024) Decoding the molecular symphony: interactions between the m6A and p53 signaling pathways in cancer. NAR Cancer 6(3):37","journal-title":"NAR Cancer"},{"issue":"1","key":"2016_CR182","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s10495-024-02037-1","volume":"30","author":"Y Shuai","year":"2025","unstructured":"Shuai Y et al (2025) The N6-methyladenosine writer METTL3 promotes breast cancer progression through YTHDF2-dependent posttranscriptional silencing of GSDMD. Apoptosis 30(1):226\u2013238","journal-title":"Apoptosis"},{"issue":"8","key":"2016_CR183","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/sj.bjc.6605299","volume":"101","author":"P Sieron","year":"2009","unstructured":"Sieron P et al (2009) DKC1 overexpression associated with prostate cancer progression. Br J Cancer 101(8):1410\u20131416","journal-title":"Br J Cancer"},{"issue":"12","key":"2016_CR184","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/genes7120129","volume":"7","author":"C Song","year":"2016","unstructured":"Song C, Sakurai M, Shiromoto Y, Nishikura K (2016) Functions of the RNA editing enzyme ADAR1 and their relevance to human diseases. Genes (Basel) 7(12):129","journal-title":"Genes (Basel)"},{"issue":"1","key":"2016_CR185","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1038\/s41467-021-25803-0","volume":"12","author":"H Song","year":"2021","unstructured":"Song H et al (2021) METTL3-mediated m6A RNA methylation promotes the anti-tumour immunity of natural killer cells. Nat Commun 12(1):5522","journal-title":"Nat Commun"},{"issue":"4","key":"2016_CR186","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.gpb.2022.09.001","volume":"21","author":"B Song","year":"2023","unstructured":"Song B et al (2023) M6A-TSHub: unveiling the context-specific m 6 A methylation and m 6 A-affecting mutations in 23 human tissues. Genomics Proteomics Bioinformatics 21(4):678\u2013694","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"14","key":"2016_CR187","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR (2022) Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell 185(14):2401\u20132421","journal-title":"Cell"},{"issue":"1\u20132","key":"2016_CR188","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","volume":"172","author":"R Su","year":"2018","unstructured":"Su R et al (2018) R-2HG exhibits anti-tumor activity by targeting FTO\/m(6)A\/MYC\/CEBPA signaling. Cell 172(1\u20132):90-105.e23","journal-title":"Cell"},{"issue":"1","key":"2016_CR189","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","volume":"38","author":"R Su","year":"2020","unstructured":"Su R et al (2020) Targeting FTO suppresses cancer stem cell maintenance and immune evasion. Cancer Cell 38(1):79-96.e11","journal-title":"Cancer Cell"},{"issue":"3","key":"2016_CR190","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s12013-023-01152-1","volume":"81","author":"Y Su","year":"2023","unstructured":"Su Y et al (2023) NSUN5-FTH1 axis inhibits ferroptosis to promote the growth of gastric cancer cells. Cell Biochem Biophys 81(3):553\u2013560","journal-title":"Cell Biochem Biophys"},{"issue":"1","key":"2016_CR191","doi-asserted-by":"publisher","first-page":"101254","DOI":"10.1016\/j.gendis.2024.101254","volume":"12","author":"Z Su","year":"2025","unstructured":"Su Z, Liu Y, Wang L, Gu W (2025) Regulation of SLC7A11 as an unconventional checkpoint in tumorigenesis through ferroptosis. Genes Dis 12(1):101254","journal-title":"Genes Dis"},{"key":"2016_CR194","doi-asserted-by":"crossref","unstructured":"Sun T et al (2025) ADAR1 editing is necessary for only a small subset of cytosolic dsRNAs to evade MDA5-mediated autoimmunity. Nat Genet:1\u201311.","DOI":"10.1038\/s41588-025-02430-9"},{"key":"2016_CR193","doi-asserted-by":"publisher","first-page":"1576895","DOI":"10.3389\/fonc.2025.1576895","volume":"15","author":"Y Sun","year":"2025","unstructured":"Sun Y et al (2025) IGF2BP3 enhances ferroptosis resistance in colon cancer by stabilizing SLC7A11 and is regulated by miR-98-5p. Front Oncol 15:1576895","journal-title":"Front Oncol"},{"issue":"45","key":"2016_CR192","doi-asserted-by":"publisher","first-page":"6906","DOI":"10.1038\/s41388-020-01475-w","volume":"39","author":"Z Sun","year":"2020","unstructured":"Sun Z et al (2020) Aberrant NSUN2-mediated m5C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma. Oncogene 39(45):6906\u20136919","journal-title":"Oncogene"},{"issue":"1","key":"2016_CR196","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.canlet.2016.02.022","volume":"376","author":"A Tanabe","year":"2016","unstructured":"Tanabe A et al (2016) RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1\u03b1 mRNA is translated. Cancer Lett 376(1):34\u201342","journal-title":"Cancer Lett"},{"issue":"1","key":"2016_CR200","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13045-025-01726-x","volume":"18","author":"J Tang","year":"2025","unstructured":"Tang J et al (2025) Necroptosis in cancer: insight from epigenetic, post-transcriptional and post-translational modifications. J Hematol Oncol 18(1):77","journal-title":"J Hematol Oncol"},{"issue":"1","key":"2016_CR199","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1186\/s12964-024-01854-w","volume":"22","author":"L Tang","year":"2024","unstructured":"Tang L et al (2024) Decoding the epitranscriptome: a new frontier for cancer therapy and drug resistance. Cell Commun Signal 22(1):513","journal-title":"Cell Commun Signal"},{"key":"2016_CR202","doi-asserted-by":"publisher","DOI":"10.1097\/cad.0000000000001809","author":"L Tang","year":"2026","unstructured":"Tang L, Huang N, Li T, Ren L (2026) Dauricine induces ferroptosis in neuroblastoma by inhibiting methyltransferase-like 1-mediated N7-methylguanosine methylation of solute carrier family 3 member 2. Anti-Cancer Drugs 37(8):500-511 . https:\/\/doi.org\/10.1097\/cad.0000000000001809","journal-title":"Anti-Cancer Drugs"},{"key":"2016_CR198","doi-asserted-by":"publisher","first-page":"677587","DOI":"10.3389\/fcell.2021.677587","volume":"9","author":"T Tang","year":"2021","unstructured":"Tang T, Han Y, Wang Y, Huang H, Qian P (2021) Programmable system of Cas13-mediated RNA modification and its biological and biomedical applications. Front Cell Dev Biol 9:677587","journal-title":"Front Cell Dev Biol"},{"key":"2016_CR197","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fgene.2019.00266","volume":"10","author":"Y Tang","year":"2019","unstructured":"Tang Y et al (2019) DRUM: inference of disease-associated m6A RNA methylation sites from a multi-layer heterogeneous network. Front Genet 10:266","journal-title":"Front Genet"},{"key":"2016_CR201","doi-asserted-by":"crossref","unstructured":"Tang Y et al (2025) METTL3-mediated m6A modification promotes ferroptosis in adenomyosis through GPX4 in a YTHDF1-dependent manner. Reproduction 170(4).","DOI":"10.1530\/REP-25-0251"},{"issue":"3","key":"2016_CR203","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nrm2312","volume":"9","author":"RC Taylor","year":"2008","unstructured":"Taylor RC, Cullen SP, Martin SJ (2008) Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9(3):231\u2013241","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2016_CR204","doi-asserted-by":"crossref","unstructured":"Tong R et al (2025) NSUN2 knockdown promotes the ferroptosis of colorectal cancer cells via m5C modification of SLC7A11 mRNA. Biochem Gen 64(1):524-537 .","DOI":"10.1007\/s10528-025-11035-0"},{"issue":"7","key":"2016_CR205","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrd2803","volume":"8","author":"D Trachootham","year":"2009","unstructured":"Trachootham D, Alexandre J, Huang P (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8(7):579\u2013591","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2016_CR206","doi-asserted-by":"publisher","first-page":"e1510","DOI":"10.1002\/wrna.1510","volume":"10","author":"L Trixl","year":"2019","unstructured":"Trixl L, Lusser A (2019) The dynamic RNA modification 5-methylcytosine and its emerging role as an epitranscriptomic mark. Wiley Interdiscip Rev RNA 10(1):e1510","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"18","key":"2016_CR207","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.15252\/embj.201591382","volume":"34","author":"F Tuorto","year":"2015","unstructured":"Tuorto F et al (2015) The tRNA methyltransferase Dnmt2 is required for accurate polypeptide synthesis during haematopoiesis. EMBO J 34(18):2350\u20132362","journal-title":"EMBO J"},{"issue":"1","key":"2016_CR208","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12943-021-01356-0","volume":"20","author":"MB Uddin","year":"2021","unstructured":"Uddin MB, Wang Z, Yang C (2021) The m6A RNA methylation regulates oncogenic signaling pathways driving cell malignant transformation and carcinogenesis. Mol Cancer 20(1):61","journal-title":"Mol Cancer"},{"issue":"1","key":"2016_CR209","doi-asserted-by":"publisher","DOI":"10.1038\/srep42271","volume":"7","author":"Y Ueda","year":"2017","unstructured":"Ueda Y et al (2017) AlkB homolog 3-mediated tRNA demethylation promotes protein synthesis in cancer cells. Sci Rep 7(1):42271","journal-title":"Sci Rep"},{"issue":"4","key":"2016_CR210","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/onc.2017.351","volume":"37","author":"A Visvanathan","year":"2018","unstructured":"Visvanathan A et al (2018) Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance. Oncogene 37(4):522\u2013533","journal-title":"Oncogene"},{"issue":"11","key":"2016_CR211","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nm.4416","volume":"23","author":"LP Vu","year":"2017","unstructured":"Vu LP et al (2017) The N 6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med 23(11):1369\u20131376","journal-title":"Nat Med"},{"key":"2016_CR220","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052597","author":"C Wang","year":"2024","unstructured":"Wang C, Yao S, Zhang T, Sun X, Bai C, Zhou P (2024) RNA N6-methyladenosine modification in DNA damage response and cancer radiotherapy. Int J Mol Sci 25(5):2597. https:\/\/doi.org\/10.3390\/ijms25052597","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2016_CR301","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2478\/jtim-2023-0103","volume":"12","author":"J Wang","year":"2024","unstructured":"Wang, J., Zhao, G., Zhao, Y., Zhao, Z., Yang, S., Zhou, A., Li, P., & Zhang, S. (2024). N6-methylation in the development, diagnosis, and treatment of gastric cancer. Journal of translational internal medicine, 12(1), 5\u201321 https:\/\/doi.org\/10.2478\/jtim-2023-0103","journal-title":"Journal of translational internal medicine"},{"issue":"20","key":"2016_CR215","doi-asserted-by":"publisher","first-page":"514","DOI":"10.15252\/embj.2020104514","volume":"39","author":"L Wang","year":"2020","unstructured":"Wang L et al (2020) m(6) A RNA methyltransferases METTL3\/14 regulate immune responses to anti-PD-1 therapy. Embo J 39(20):514","journal-title":"Embo J"},{"key":"2016_CR221","doi-asserted-by":"crossref","unstructured":"Wang L et al (2025b) Hypoxia-induced HIF1A impairs sorafenib sensitivity in hepatocellular carcinoma through NSUN2-mediated stabilization of GDF15. Cell Signall:112076.","DOI":"10.1016\/j.cellsig.2025.112076"},{"issue":"3","key":"2016_CR217","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10495-023-01817-5","volume":"28","author":"K Wang","year":"2023","unstructured":"Wang K et al (2023b) m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation. Apoptosis 28(3):627\u2013638","journal-title":"Apoptosis"},{"issue":"2","key":"2016_CR218","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41419-023-05661-y","volume":"14","author":"N Wang","year":"2023","unstructured":"Wang N et al (2023c) m5C-dependent cross-regulation between nuclear reader ALYREF and writer NSUN2 promotes urothelial bladder cancer malignancy through facilitating RABL6\/TK1 mRNAs splicing and stabilization. Cell Death Dis 14(2):139","journal-title":"Cell Death Dis"},{"issue":"7755","key":"2016_CR214","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang W et al (2019) CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy. Nature 569(7755):270\u2013274","journal-title":"Nature"},{"issue":"7481","key":"2016_CR212","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature12730","volume":"505","author":"X Wang","year":"2014","unstructured":"Wang X et al (2014) N 6-methyladenosine-dependent regulation of messenger RNA stability. Nature 505(7481):117\u2013120","journal-title":"Nature"},{"issue":"6","key":"2016_CR213","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","volume":"161","author":"X Wang","year":"2015","unstructured":"Wang X et al (2015) N6-methyladenosine modulates messenger RNA translation efficiency. Cell 161(6):1388\u20131399","journal-title":"Cell"},{"key":"2016_CR219","doi-asserted-by":"publisher","first-page":"1621585","DOI":"10.3389\/fimmu.2025.1621585","volume":"16","author":"X Wang","year":"2025","unstructured":"Wang X, Yin F, He Y, Qiao Y, Yan Y, Ma J (2025a) Deciphering the mechanistic roles of ADARs in cancer pathogenesis, tumor immune evasion, and drug resistance. Front Immunol 16:1621585","journal-title":"Front Immunol"},{"issue":"2","key":"2016_CR216","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/1878-0261.13326","volume":"17","author":"Z Wang","year":"2023","unstructured":"Wang Z, Zhou J, Zhang H, Ge L, Li J, Wang H (2023a) RNA m(6) A methylation in cancer. Mol Oncol 17(2):195\u2013229","journal-title":"Mol Oncol"},{"issue":"6","key":"2016_CR222","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.molcel.2018.08.011","volume":"71","author":"J Wei","year":"2018","unstructured":"Wei J et al (2018) Differential m6A, m6Am, and m1A demethylation mediated by FTO in the cell nucleus and cytoplasm. Mol Cell 71(6):973-985.e8","journal-title":"Mol Cell"},{"issue":"9","key":"2016_CR223","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41423-022-00905-x","volume":"19","author":"X Wei","year":"2022","unstructured":"Wei X et al (2022) Role of pyroptosis in inflammation and cancer. Cell Mol Immunol 19(9):971\u2013992","journal-title":"Cell Mol Immunol"},{"key":"2016_CR224","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2026.01.021","author":"C Wen","year":"2026","unstructured":"Wen C et al (2026) M6A methylation in ferroptosis regulation: mechanisms, targets, and therapeutic interventions. J Adv Res. https:\/\/doi.org\/10.1016\/j.jare.2026.01.021","journal-title":"J Adv Res"},{"issue":"2","key":"2016_CR225","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","volume":"22","author":"H Weng","year":"2018","unstructured":"Weng H et al (2018) METTL14 inhibits hematopoietic stem\/progenitor differentiation and promotes leukemogenesis via mRNA m6A modification. Cell Stem Cell 22(2):191-205. e9","journal-title":"Cell Stem Cell"},{"issue":"2","key":"2016_CR226","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41576-020-00295-8","volume":"22","author":"D Wiener","year":"2021","unstructured":"Wiener D, Schwartz S (2021) The epitranscriptome beyond m6A. Nat Rev Genet 22(2):119\u2013131","journal-title":"Nat Rev Genet"},{"issue":"4","key":"2016_CR227","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.3390\/ijms22041949","volume":"22","author":"E Wilkinson","year":"2021","unstructured":"Wilkinson E, Cui Y-H, He Y-Y (2021) Context-dependent roles of RNA modifications in stress responses and diseases. Int J Mol Sci 22(4):1949","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2016_CR228","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1038\/s41587-020-0572-6","volume":"38","author":"C Wilson","year":"2020","unstructured":"Wilson C, Chen PJ, Miao Z, Liu DR (2020) Programmable m6A modification of cellular RNAs with a Cas13-directed methyltransferase. Nat Biotechnol 38(12):1431\u20131440","journal-title":"Nat Biotechnol"},{"issue":"2","key":"2016_CR229","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41590-018-0275-z","volume":"20","author":"R Winkler","year":"2019","unstructured":"Winkler R et al (2019) m(6)A modification controls the innate immune response to infection by targeting type I interferons. Nat Immunol 20(2):173\u2013182","journal-title":"Nat Immunol"},{"issue":"12","key":"2016_CR230","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/s41592-019-0617-2","volume":"16","author":"RE Workman","year":"2019","unstructured":"Workman RE et al (2019) Nanopore native RNA sequencing of a human poly (A) transcriptome. Nat Methods 16(12):1297\u20131305","journal-title":"Nat Methods"},{"issue":"1","key":"2016_CR232","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s12672-025-02330-8","volume":"16","author":"B Wu","year":"2025","unstructured":"Wu B, Li D, Wang Y, Pan T, Xu J, Li L (2025) The m6A methyltransferase METTL3 affects ferroptosis in non-small cell lung cancer by regulating the PTEN\/PI3K\/AKT pathway. Discov Oncol 16(1):559","journal-title":"Discov Oncol"},{"issue":"11","key":"2016_CR231","doi-asserted-by":"publisher","first-page":"e70089","DOI":"10.1002\/ctm2.70089","volume":"14","author":"K Wu","year":"2024","unstructured":"Wu K et al (2024) Targeting METTL3 as a checkpoint to enhance T cells for tumour immunotherapy. Clin Transl Med 14(11):e70089","journal-title":"Clin Transl Med"},{"issue":"19","key":"2016_CR233","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1016\/j.molcel.2024.09.003","volume":"84","author":"B Xhemal\u00e7e","year":"2024","unstructured":"Xhemal\u00e7e B, Miller KM, Gromak N (2024) Epitranscriptome in action: RNA modifications in the DNA damage response. Mol Cell 84(19):3610\u20133626","journal-title":"Mol Cell"},{"issue":"2","key":"2016_CR234","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12031-016-0788-6","volume":"60","author":"Z Xi","year":"2016","unstructured":"Xi Z, Xue Y, Zheng J, Liu X, Ma J, Liu Y (2016) WTAP expression predicts poor prognosis in malignant glioma patients. J Mol Neurosci 60(2):131\u2013136","journal-title":"J Mol Neurosci"},{"issue":"9","key":"2016_CR235","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41419-019-1883-8","volume":"10","author":"X Xia","year":"2019","unstructured":"Xia X et al (2019) The role of pyroptosis in cancer: pro-cancer or pro-\u201chost\u201d? Cell Death Dis 10(9):650","journal-title":"Cell Death Dis"},{"issue":"7646","key":"2016_CR236","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nature21671","volume":"543","author":"Y Xiang","year":"2017","unstructured":"Xiang Y et al (2017) RNA m6A methylation regulates the ultraviolet-induced DNA damage response. Nature 543(7646):573\u2013576","journal-title":"Nature"},{"issue":"18","key":"2016_CR237","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1158\/0008-5472.CAN-20-0132","volume":"80","author":"L Xiao","year":"2020","unstructured":"Xiao L et al (2020) FTO inhibition enhances the antitumor effect of temozolomide by targeting MYC-miR-155\/23a cluster-MXI1 feedback circuit in glioma. Cancer Res 80(18):3945\u20133958","journal-title":"Cancer Res"},{"key":"2016_CR238","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2025.04.003","author":"S Xiao","year":"2025","unstructured":"Xiao S, Duan S, Caligiuri MA, Ma S, Yu J (2025) YTHDF2: a key RNA reader and antitumor target. Trends Immunol 46(6):485-498 . https:\/\/doi.org\/10.1016\/j.it.2025.04.003","journal-title":"Trends Immunol"},{"issue":"2","key":"2016_CR239","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.apsb.2021.08.028","volume":"12","author":"G Xie","year":"2022","unstructured":"Xie G et al (2022) A novel inhibitor of N (6)-methyladenosine demethylase FTO induces mRNA methylation and shows anti-cancer activities. Acta Pharm Sin B 12(2):853\u2013866","journal-title":"Acta Pharm Sin B"},{"key":"2016_CR240","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-026-04279-2","author":"Y Xie","year":"2026","unstructured":"Xie Y et al (2026) RNA modifications and cancer ferroptosis. Cancer Cell Int 26(191) . https:\/\/doi.org\/10.1186\/s12935-026-04279-2","journal-title":"Cancer Cell Int"},{"issue":"2","key":"2016_CR241","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41588-019-0554-0","volume":"52","author":"G Xu","year":"2020","unstructured":"Xu G et al (2020) ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer. Nat Genet 52(2):198\u2013207","journal-title":"Nat Genet"},{"issue":"12","key":"2016_CR242","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1080\/15476286.2021.1925460","volume":"18","author":"L Xu","year":"2021","unstructured":"Xu L et al (2021) RNA modifications act as regulators of cell death. RNA Biol 18(12):2183\u20132193","journal-title":"RNA Biol"},{"issue":"1","key":"2016_CR243","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12935-021-02433-6","volume":"22","author":"Y Xu","year":"2022","unstructured":"Xu Y et al (2022) METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m6A modification. Cancer Cell Int 22(1):11","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2016_CR244","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1038\/s41467-023-37398-9","volume":"14","author":"A Xu","year":"2023","unstructured":"Xu A et al (2023) Rewired m6A epitranscriptomic networks link mutant p53 to neoplastic transformation. Nat Commun 14(1):1694","journal-title":"Nat Commun"},{"issue":"8","key":"2016_CR245","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3390\/biom15081088","volume":"15","author":"B Xu","year":"2025","unstructured":"Xu B, Maimaitijiang A, Nuerbiyamu D, Su Z, Li W (2025) The multifaceted role of p53 in cancer molecular biology: insights for precision diagnosis and therapeutic breakthroughs. Biomolecules 15(8):1088","journal-title":"Biomolecules"},{"key":"2016_CR246","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-026-08615-2","author":"X Xu","year":"2026","unstructured":"Xu X et al (2026) Reduced YTHDF2 inhibits PD-L1 expression by stabilizing m6A-containing SPOP mRNA in colorectal cancer. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-026-08615-2","journal-title":"Cell Death Dis"},{"key":"2016_CR247","doi-asserted-by":"publisher","first-page":"1549588","DOI":"10.3389\/fcell.2025.1549588","volume":"13","author":"W Xue","year":"2025","unstructured":"Xue W, Zhao Y, Zhang G, Li Z, Li J, Fei X (2025) The role of m5C, m1A and m7G modifications in tumors of urinary system. Front Cell Dev Biol 13:1549588","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"2016_CR248","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/s41422-018-0097-4","volume":"28","author":"F Yan","year":"2018","unstructured":"Yan F et al (2018) A dynamic N(6)-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors. Cell Res 28(11):1062\u20131076","journal-title":"Cell Res"},{"key":"2016_CR249","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.110509","author":"L Yan","year":"2025","unstructured":"Yan L, Wang J, Li B, Guo J, Jia R (2025) The splicing factor SRSF6 mediates ferroptosis resistance in head and neck squamous cell carcinoma through induction of stearoyl-CoA desaturase. J Biol Chem 301(9):110509 . https:\/\/doi.org\/10.1016\/j.jbc.2025.110509","journal-title":"J Biol Chem"},{"issue":"1","key":"2016_CR250","doi-asserted-by":"publisher","first-page":"6545728","DOI":"10.1155\/2021\/6545728","volume":"2021","author":"B Yang","year":"2021","unstructured":"Yang B, Chen Q (2021) Cross-talk between oxidative stress and m6A RNA methylation in cancer. Oxid Med Cell Longev 2021(1):6545728","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"2016_CR254","doi-asserted-by":"publisher","first-page":"e2833","DOI":"10.1038\/cddis.2017.12","volume":"8","author":"CC Yang","year":"2017","unstructured":"Yang CC et al (2017) ADAR1-mediated 3\u2019 UTR editing and expression control of antiapoptosis genes fine-tunes cellular apoptosis response. Cell Death Dis 8(5):e2833","journal-title":"Cell Death Dis"},{"issue":"1","key":"2016_CR251","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS et al (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156(1):317\u2013331","journal-title":"Cell"},{"issue":"34","key":"2016_CR252","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","volume":"113","author":"WS Yang","year":"2016","unstructured":"Yang WS, Kim KJ, Gaschler MM, Patel M, Shchepinov MS, Stockwell BR (2016) Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci U S A 113(34):E4966\u2013E4975","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2016_CR253","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/cr.2017.55","volume":"27","author":"X Yang","year":"2017","unstructured":"Yang X et al (2017) 5-methylcytosine promotes mRNA export\u2014NSUN2 as the methyltransferase and ALYREF as an m5C reader. Cell Res 27(5):606\u2013625","journal-title":"Cell Res"},{"issue":"1","key":"2016_CR255","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-020-1146-4","volume":"19","author":"X Yang","year":"2020","unstructured":"Yang X et al (2020) METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST. Mol Cancer 19(1):46","journal-title":"Mol Cancer"},{"issue":"1","key":"2016_CR256","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","volume":"35","author":"F Yang","year":"2023","unstructured":"Yang F et al (2023) Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy. Cell Metab 35(1):84-100.e8","journal-title":"Cell Metab"},{"key":"2016_CR257","doi-asserted-by":"crossref","unstructured":"Yang Y et al (2025) EF24 targets METTL3 to reprogram m6A methylation and induce ferroptosis: an epitranscriptomic mechanism with therapeutical potential for glioma. Cell Commun Signal 24(1):32.","DOI":"10.1186\/s12964-025-02583-4"},{"issue":"7860","key":"2016_CR258","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","volume":"593","author":"E Yankova","year":"2021","unstructured":"Yankova E et al (2021) Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature 593(7860):597\u2013601","journal-title":"Nature"},{"issue":"3","key":"2016_CR259","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41419-022-04711-1","volume":"13","author":"X Yao","year":"2022","unstructured":"Yao X et al (2022) YTHDF1 upregulation mediates hypoxia-dependent breast cancer growth and metastasis through regulating PKM2 to affect glycolysis. Cell Death Dis 13(3):258","journal-title":"Cell Death Dis"},{"issue":"1","key":"2016_CR260","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1186\/s12935-020-01696-9","volume":"20","author":"AA Yarmishyn","year":"2020","unstructured":"Yarmishyn AA et al (2020) Musashi-1 promotes cancer stem cell properties of glioblastoma cells via upregulation of YTHDF1. Cancer Cell Int 20(1):597","journal-title":"Cancer Cell Int"},{"issue":"26","key":"2016_CR261","doi-asserted-by":"publisher","first-page":"12072","DOI":"10.7150\/thno.51231","volume":"10","author":"J Ye","year":"2020","unstructured":"Ye J et al (2020) YTHDF1-enhanced iron metabolism depends on TFRC m6A methylation. Theranostics 10(26):12072","journal-title":"Theranostics"},{"key":"2016_CR264","doi-asserted-by":"publisher","DOI":"10.3390\/ph19060858","author":"JL Yi","year":"2026","unstructured":"Yi JL, Zhu JX, Huang WF, Yi LT (2026) Mechanistic networks, cellular specificity, and therapeutic opportunities of ferroptosis in ulcerative colitis. Pharmaceuticals (Basel) 19(6):858. https:\/\/doi.org\/10.3390\/ph19060858","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"2016_CR263","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3390\/ph19060858","volume":"19","author":"J-L Yi","year":"2026","unstructured":"Yi J-L, Zhu J-X, Huang W-F, Yi L-T (2026) Mechanistic networks, cellular specificity, and therapeutic opportunities of ferroptosis in ulcerative colitis. Pharmaceuticals (Basel) 19(6):858","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"2016_CR262","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12943-020-01233-2","volume":"19","author":"Y-C Yi","year":"2020","unstructured":"Yi Y-C, Chen X-Y, Zhang J, Zhu J-S (2020) Novel insights into the interplay between m6A modification and noncoding RNAs in cancer. Mol Cancer 19(1):121","journal-title":"Mol Cancer"},{"issue":"10","key":"2016_CR265","doi-asserted-by":"publisher","first-page":"5779","DOI":"10.1093\/nar\/gkab415","volume":"49","author":"F Yu","year":"2021","unstructured":"Yu F et al (2021) Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response. Nucleic Acids Res 49(10):5779\u20135797","journal-title":"Nucleic Acids Res"},{"key":"2016_CR266","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S205730","author":"HL Yu","year":"2019","unstructured":"Yu HL, Ma XD, Tong JF, Li JQ, Guan XJ, Yang JH (2019) WTAP is a prognostic marker of high-grade serous ovarian cancer and regulates the progression of ovarian cancer cells. OncoTargets Ther 12(2019):6191-6201. . https:\/\/doi.org\/10.2147\/OTT.S205730","journal-title":"OncoTargets Ther"},{"issue":"1","key":"2016_CR267","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13148-025-01994-x","volume":"17","author":"Y Yuan","year":"2025","unstructured":"Yuan Y et al (2025) NSUN2 promotes leukemogenesis by ferritin heavy chain 1-mediated anti-ferroptosis and enhancing global protein synthesis in an m(5)C-dependent manner in B-acute lymphoblastic leukemia. Clin Epigenet 17(1):179","journal-title":"Clin Epigenet"},{"issue":"7","key":"2016_CR268","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.cell.2020.05.012","volume":"181","author":"S Zaccara","year":"2020","unstructured":"Zaccara S, Jaffrey SR (2020) A unified model for the function of YTHDF proteins in regulating m6A-modified mRNA. Cell 181(7):1582-1595.e18","journal-title":"Cell"},{"issue":"10","key":"2016_CR269","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara S, Ries RJ, Jaffrey SR (2019) Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol 20(10):608\u2013624","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2016_CR270","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13045-020-00951-w","volume":"13","author":"C Zeng","year":"2020","unstructured":"Zeng C, Huang W, Li Y, Weng H (2020) Roles of METTL3 in cancer: mechanisms and therapeutic targeting. J Hematol Oncol 13(1):117","journal-title":"J Hematol Oncol"},{"issue":"1","key":"2016_CR271","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1186\/s12885-025-14729-1","volume":"25","author":"Y Zeng","year":"2025","unstructured":"Zeng Y et al (2025) METTL16-dependent GPX4 m6A modification links ferroptosis to NSCLC TKIs resistance. BMC Cancer 25(1):1335","journal-title":"BMC Cancer"},{"issue":"14","key":"2016_CR272","doi-asserted-by":"publisher","first-page":"E2047","DOI":"10.1073\/pnas.1602883113","volume":"113","author":"C Zhang","year":"2016","unstructured":"Zhang C et al (2016a) Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m\u2076A-demethylation of NANOG mRNA. Proc Natl Acad Sci U S A 113(14):E2047\u2013E2056","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"40","key":"2016_CR273","doi-asserted-by":"publisher","first-page":"64527","DOI":"10.18632\/oncotarget.11743","volume":"7","author":"C Zhang","year":"2016","unstructured":"Zhang C et al (2016b) Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells. Oncotarget 7(40):64527\u201364542","journal-title":"Oncotarget"},{"issue":"1","key":"2016_CR284","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41419-024-07317-x","volume":"16","author":"C Zhang","year":"2025","unstructured":"Zhang C et al (2025a) METTL3 inhibition promotes radiosensitivity in hepatocellular carcinoma through regulation of SLC7A11 expression. Cell Death Dis 16(1):9","journal-title":"Cell Death Dis"},{"issue":"1","key":"2016_CR281","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41420-023-01746-x","volume":"9","author":"G Zhang","year":"2023","unstructured":"Zhang G et al (2023a) Targeting AKT induced ferroptosis through FTO\/YTHDF2-dependent GPX4 m6A methylation up-regulating and degradating in colorectal cancer. Cell Death Discov 9(1):457","journal-title":"Cell Death Discov"},{"issue":"1","key":"2016_CR285","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12929-024-01100-y","volume":"32","author":"H Zhang","year":"2025","unstructured":"Zhang H et al (2025b) N6-methyladenosine RNA modification regulates the transcription of SLC7A11 through KDM6B and GATA3 to modulate ferroptosis. J Biomed Sci 32(1):8","journal-title":"J Biomed Sci"},{"issue":"1","key":"2016_CR278","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41416-022-01757-y","volume":"127","author":"L Zhang","year":"2022","unstructured":"Zhang L, Luo X, Qiao S (2022a) METTL14-mediated N6-methyladenosine modification of Pten mRNA inhibits tumour progression in clear-cell renal cell carcinoma. Br J Cancer 127(1):30","journal-title":"Br J Cancer"},{"issue":"4","key":"2016_CR274","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ccell.2017.02.013","volume":"31","author":"S Zhang","year":"2017","unstructured":"Zhang S et al (2017) M6A demethylase ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by sustaining FOXM1 expression and cell proliferation program. Cancer Cell 31(4):591-606. e6","journal-title":"Cancer Cell"},{"issue":"7914","key":"2016_CR280","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41586-022-04753-7","volume":"606","author":"T Zhang","year":"2022","unstructured":"Zhang T et al (2022c) ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis. Nature 606(7914):594\u2013602","journal-title":"Nature"},{"issue":"23","key":"2016_CR276","doi-asserted-by":"publisher","first-page":"7041","DOI":"10.7150\/jca.64061","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X et al (2021b) N6-methyladenosine regulates ATM expression and downstream signaling. J Cancer 12(23):7041","journal-title":"J Cancer"},{"issue":"1","key":"2016_CR283","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-024-01847-0","volume":"26","author":"X Zhang","year":"2024","unstructured":"Zhang X et al (2024a) NSUN2\/YBX1 promotes the progression of breast cancer by enhancing HGH1 mRNA stability through m(5)C methylation. Breast Cancer Res 26(1):94","journal-title":"Breast Cancer Res"},{"key":"2016_CR286","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114885","author":"X Zhang","year":"2024","unstructured":"Zhang X et al (2024b) STUB1-mediated ubiquitination and degradation of NSUN2 promotes hepatocyte ferroptosis by decreasing m5C methylation of Gpx4 mRNA. Cell Rep 43(11):114885 . https:\/\/doi.org\/10.1016\/j.celrep.2024.114885","journal-title":"Cell Rep"},{"issue":"3","key":"2016_CR277","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101058","volume":"297","author":"X Zhang","year":"2021","unstructured":"Zhang X, Li X, Jia H, An G, Ni J (2021c) The m(6)A methyltransferase METTL3 modifies PGC-1\u03b1 mRNA promoting mitochondrial dysfunction and oxLDL-induced inflammation in monocytes. J Biol Chem 297(3):101058","journal-title":"J Biol Chem"},{"issue":"2","key":"2016_CR275","first-page":"1","volume":"46","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Liu S, Zhao T, Dang C (2021a) METTL3-mediated m6A modification of Bcl-2 mRNA promotes non-small cell lung cancer progression Corrigendum in\/10.3892\/or. 2023.8502. Oncol Rep 46(2):1\u201310","journal-title":"Oncol Rep"},{"issue":"10","key":"2016_CR279","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1038\/s12276-022-00821-0","volume":"54","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Lu L, Li X (2022b) Detection technologies for RNA modifications. Exp Mol Med 54(10):1601\u20131616","journal-title":"Exp Mol Med"},{"issue":"D1","key":"2016_CR282","doi-asserted-by":"publisher","first-page":"D106","DOI":"10.1093\/nar\/gkac1061","volume":"51","author":"Y Zhang","year":"2023","unstructured":"Zhang Y et al (2023b) DirectRMDB: a database of post-transcriptional RNA modifications unveiled from direct RNA sequencing technology. Nucleic Acids Res 51(D1):D106\u2013D116","journal-title":"Nucleic Acids Res"},{"key":"2016_CR287","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2026.03.046","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, Meng T, Chen L, Li J, Li K (2026) METTL3-mediated m6A modification contributes to anlotinib resistance in osteosarcoma by regulating ferroptosis via the circFAM120B\/miR-330-3p\/PRKDC axis. Free Radic Biol Med 249:409-423 . https:\/\/doi.org\/10.1016\/j.freeradbiomed.2026.03.046","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"2016_CR289","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrm.2016.132","volume":"18","author":"BS Zhao","year":"2017","unstructured":"Zhao BS, Roundtree IA, He C (2017) Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol 18(1):31\u201342","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"2016_CR290","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/s41418-025-01453-3","volume":"32","author":"X Zhao","year":"2025","unstructured":"Zhao X et al (2025) Protein kinase A regulates ferroptosis by controlling GPX4 m6A modification through phosphorylation of ALKBH5. Cell Death Differ 32(6):1058\u20131070","journal-title":"Cell Death Differ"},{"key":"2016_CR288","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1706557","volume":"16","author":"X Zhao","year":"2025","unstructured":"Zhao X, Guan S (2025) Epitranscriptomic control of cancer immunity and therapy resistance. Front Immunol 16:1706557","journal-title":"Front Immunol"},{"issue":"1","key":"2016_CR291","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","volume":"49","author":"G Zheng","year":"2013","unstructured":"Zheng G et al (2013) ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell 49(1):18\u201329","journal-title":"Mol Cell"},{"issue":"D1","key":"2016_CR292","doi-asserted-by":"publisher","first-page":"D139","DOI":"10.1093\/nar\/gkx895","volume":"46","author":"Y Zheng","year":"2018","unstructured":"Zheng Y et al (2018) M6AVar: a database of functional variants involved in m6A modification. Nucleic Acids Res 46(D1):D139\u2013D145","journal-title":"Nucleic Acids Res"},{"issue":"7574","key":"2016_CR293","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nature15377","volume":"526","author":"J Zhou","year":"2015","unstructured":"Zhou J, Wan J, Gao X, Zhang X, Jaffrey SR, Qian SB (2015) Dynamic m(6)A mRNA methylation directs translational control of heat shock response. Nature 526(7574):591\u2013594","journal-title":"Nature"},{"issue":"1","key":"2016_CR294","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q et al (2024a) Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther 9(1):55","journal-title":"Signal Transduct Target Ther"},{"key":"2016_CR295","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24432","author":"S Zhou","year":"2024","unstructured":"Zhou S et al (2024b) Metformin enhances METTL14-mediated m6A methylation to alleviate NIT-1 cells apoptosis induced by hydrogen peroxide. Heliyon 10(2):e24432 . https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24432","journal-title":"Heliyon"},{"key":"2016_CR296","doi-asserted-by":"crossref","unstructured":"Zhou Y et al (2026) Pyroptosis regulated by m6A modification: implications for pyroptosis-related disease therapy. J Innate Immun 18(1):265-286.","DOI":"10.1159\/000552343"},{"issue":"7","key":"2016_CR297","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.7150\/ijbs.130175","volume":"22","author":"Z Zhu","year":"2026","unstructured":"Zhu Z et al (2026) PUS1 drives renal cancer progression by preventing formation of endogenous double-stranded RNAs. Int J Biol Sci 22(7):3749\u20133768","journal-title":"Int J Biol Sci"},{"issue":"2","key":"2016_CR298","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.stem.2016.05.004","volume":"19","author":"MA Zipeto","year":"2016","unstructured":"Zipeto MA et al (2016) ADAR1 activation drives leukemia stem cell self-renewal by impairing Let-7 biogenesis. Cell Stem Cell 19(2):177\u2013191","journal-title":"Cell Stem Cell"},{"issue":"3","key":"2016_CR299","doi-asserted-by":"publisher","first-page":"e1621","DOI":"10.1002\/ctm2.1621","volume":"14","author":"S Zou","year":"2024","unstructured":"Zou S et al (2024) NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization. Clin Transl Med 14(3):e1621","journal-title":"Clin Transl Med"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-02016-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-026-02016-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-02016-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T07:03:19Z","timestamp":1787814199000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-026-02016-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":298,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2016"],"URL":"https:\/\/doi.org\/10.1007\/s10142-026-02016-6","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"assertion":[{"value":"25 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declared no potential conflicts of interest concerning this article\u2019s research, authorship, and publication.","order":1,"name":"Ethics","label":"Disclosure of potential conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Research involving Human Participants and\/or Animals","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":7,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have used Grammarly (\n                      \n                      ) for improving the language and correcting the grammatical errors within the manuscript. Additionally all the diagrams in the manuscript were created using Biorender (\n                      \n                      ).","order":8,"name":"Ethics","label":"Statements and declarations","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"236"}}